Literature DB >> 26324897

Competitive exclusion by autologous antibodies can prevent broad HIV-1 antibodies from arising.

Shishi Luo1, Alan S Perelson2.   

Abstract

The past decade has seen the discovery of numerous broad and potent monoclonal antibodies against HIV type 1 (HIV-1). Eliciting these antibodies via vaccination appears to be remarkably difficult, not least because they arise late in infection and are highly mutated relative to germline antibody sequences. Here, using a computational model, we show that broad antibodies could in fact emerge earlier and be less mutated, but that they may be prevented from doing so as a result of competitive exclusion by the autologous antibody response. We further find that this competitive exclusion is weaker in infections founded by multiple distinct strains, with broadly neutralizing antibodies emerging earlier than in infections founded by a single strain. Our computational model simulates coevolving multitype virus and antibody populations. Broadly neutralizing antibodies may therefore be easier for the adaptive immune system to generate than previously thought. If less mutated broad antibodies exist, it may be possible to elicit them with a vaccine containing a mixture of diverse virus strains.

Entities:  

Keywords:  broadly neutralizing antibodies; coevolutionary dynamics; competitive exclusion; human immunodeficiency virus; mathematical modeling

Mesh:

Substances:

Year:  2015        PMID: 26324897      PMCID: PMC4577154          DOI: 10.1073/pnas.1505207112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Variable efficacy of repeated annual influenza vaccination.

Authors:  D J Smith; S Forrest; D H Ackley; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 2.  Germinal centers.

Authors:  Gabriel D Victora; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

Review 3.  The Antibody Response against HIV-1.

Authors:  Julie Overbaugh; Lynn Morris
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

4.  IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences.

Authors:  Véronique Giudicelli; Xavier Brochet; Marie-Paule Lefranc
Journal:  Cold Spring Harb Protoc       Date:  2011-06-01

Review 5.  Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies.

Authors:  Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

6.  B cell responses to HIV-1 infection and vaccination: pathways to preventing infection.

Authors:  Barton F Haynes; M Anthony Moody; Hua-Xin Liao; Laurent Verkoczy; Georgia D Tomaras
Journal:  Trends Mol Med       Date:  2010-11-26       Impact factor: 11.951

7.  Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.

Authors:  Lei Chen; Young Do Kwon; Tongqing Zhou; Xueling Wu; Sijy O'Dell; Lisa Cavacini; Ann J Hessell; Marie Pancera; Min Tang; Ling Xu; Zhi-Yong Yang; Mei-Yun Zhang; James Arthos; Dennis R Burton; Dimiter S Dimitrov; Gary J Nabel; Marshall R Posner; Joseph Sodroski; Richard Wyatt; John R Mascola; Peter D Kwong
Journal:  Science       Date:  2009-11-20       Impact factor: 47.728

8.  Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes.

Authors:  Bryan S Briney; Jordan R Willis; James E Crowe
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

9.  Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

Authors:  Dan H Barouch; James B Whitney; Brian Moldt; Florian Klein; Thiago Y Oliveira; Jinyan Liu; Kathryn E Stephenson; Hui-Wen Chang; Karthik Shekhar; Sanjana Gupta; Joseph P Nkolola; Michael S Seaman; Kaitlin M Smith; Erica N Borducchi; Crystal Cabral; Jeffrey Y Smith; Stephen Blackmore; Srisowmya Sanisetty; James R Perry; Matthew Beck; Mark G Lewis; William Rinaldi; Arup K Chakraborty; Pascal Poignard; Michel C Nussenzweig; Dennis R Burton
Journal:  Nature       Date:  2013-10-30       Impact factor: 49.962

10.  Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.

Authors:  Penny L Moore; Nthabeleng Ranchobe; Bronwen E Lambson; Elin S Gray; Eleanor Cave; Melissa-Rose Abrahams; Gama Bandawe; Koleka Mlisana; Salim S Abdool Karim; Carolyn Williamson; Lynn Morris
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

View more
  21 in total

1.  Optimizing immunization protocols to elicit broadly neutralizing antibodies.

Authors:  Kayla G Sprenger; Joy E Louveau; Pranav M Murugan; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-03       Impact factor: 11.205

2.  Optimal immunization cocktails can promote induction of broadly neutralizing Abs against highly mutable pathogens.

Authors:  J Scott Shaffer; Penny L Moore; Mehran Kardar; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

3.  How Germinal Centers Evolve Broadly Neutralizing Antibodies: the Breadth of the Follicular Helper T Cell Response.

Authors:  Rob J De Boer; Alan S Perelson
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

Review 4.  The challenges of modelling antibody repertoire dynamics in HIV infection.

Authors:  Shishi Luo; Alan S Perelson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

5.  RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection.

Authors:  Eric Lewitus; Eric Sanders-Buell; Meera Bose; Anne Marie O'Sullivan; Kultida Poltavee; Yifan Li; Hongjun Bai; Thembi Mdluli; Gina Donofrio; Bonnie Slike; Hong Zhao; Kim Wong; Lennie Chen; Shana Miller; Jenica Lee; Bahar Ahani; Steven Lepore; Sevan Muhammad; Rebecca Grande; Ursula Tran; Vincent Dussupt; Letzibeth Mendez-Rivera; Sorachai Nitayaphan; Jaranit Kaewkungwal; Punnee Pitisuttithum; Supachai Rerks-Ngarm; Robert J O'Connell; Holly Janes; Peter B Gilbert; Robert Gramzinski; Sandhya Vasan; Merlin L Robb; Nelson L Michael; Shelly J Krebs; Joshua T Herbeck; Paul T Edlefsen; James I Mullins; Jerome H Kim; Sodsai Tovanabutra; Morgane Rolland
Journal:  Virus Evol       Date:  2021-07-09

6.  Determinants of HIV-1 broadly neutralizing antibody induction.

Authors:  Peter Rusert; Roger D Kouyos; Claus Kadelka; Hanna Ebner; Merle Schanz; Michael Huber; Dominique L Braun; Nathanael Hozé; Alexandra Scherrer; Carsten Magnus; Jacqueline Weber; Therese Uhr; Valentina Cippa; Christian W Thorball; Herbert Kuster; Matthias Cavassini; Enos Bernasconi; Matthias Hoffmann; Alexandra Calmy; Manuel Battegay; Andri Rauch; Sabine Yerly; Vincent Aubert; Thomas Klimkait; Jürg Böni; Jacques Fellay; Roland R Regoes; Huldrych F Günthard; Alexandra Trkola
Journal:  Nat Med       Date:  2016-09-26       Impact factor: 53.440

7.  Dynamics of virus and immune response in multi-epitope network.

Authors:  Cameron J Browne; Hal L Smith
Journal:  J Math Biol       Date:  2018-02-23       Impact factor: 2.259

8.  Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies.

Authors:  Raymond H Y Louie; Kevin J Kaczorowski; John P Barton; Arup K Chakraborty; Matthew R McKay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

9.  Host-Pathogen Coevolution and the Emergence of Broadly Neutralizing Antibodies in Chronic Infections.

Authors:  Armita Nourmohammad; Jakub Otwinowski; Joshua B Plotkin
Journal:  PLoS Genet       Date:  2016-07-21       Impact factor: 5.917

Review 10.  Modeling Kick-Kill Strategies toward HIV Cure.

Authors:  Esteban A Hernandez-Vargas
Journal:  Front Immunol       Date:  2017-08-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.